Pfizer’s November 9th announcement of an effective COVID-19 vaccine triggered the most extensive one-day rotation in style factors we have ever seen. Investors flipped from Large Growth—the market’s dominating style over the past few years—and found new friends in Value and Small Cap. This rotation continued through November, to the point that Value and Small Cap each had their best single-month return in 30 years.
Dec
17
2020
The “Pfizer Factor Flip” And Fund Flows
Login
For full access, please enter your credentials.
Not a Subscriber?
If you are interested in subscribing to The Leuthold Group, contact us online or give us a call at 612-332-1567.
Contact UsAbout The Author
![Scott Opsal / Director of Research & Equities](https://leuthold.imgix.net/leutholdgroup.com/site_files/authors/DSC_2797_LR_Scott.jpg?h=150&w=150&fit=crop&fp-y=.15)